Myobloc (Solstice Neurosciences, LLC)
Welcome to the PulseAid listing for the Myobloc drug offered from Solstice Neurosciences, LLC. This Acetylcholine Release Inhibitor [EPC],Acetylcholine Release Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Solstice Neurosciences, LLC |
| NON-PROPRIETARY NAME: | rimabotulinumtoxinB |
| SUBSTANCE NAME: | RIMABOTULINUMTOXINB |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Acetylcholine Release Inhibitor [EPC],Acetylcholine Release Inhibitors [MoA] |
| ROUTE: | INTRAMUSCULAR |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2000-12-08 |
| END MARKETING DATE: | 0000-00-00 |
Myobloc HUMAN PRESCRIPTION DRUG Details:
| Item Description | Myobloc from Solstice Neurosciences, LLC |
| LABELER NAME: | Solstice Neurosciences, LLC |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 2500([USP’U]/.5mL) |
| START MARKETING DATE: | 2000-12-08 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 10454-710_fe96358c-e490-47bd-b992-3783022b7aff |
| PRODUCT NDC: | 10454-710 |
| APPLICATION NUMBER: | BLA103846 |
Other RIMABOTULINUMTOXINB Pharmaceutical Manufacturers / Labelers:
